What is TIGR Matrix and why is it described as the first long-term resorbable 100% synthetic mesh?

TIGR Matrix is a fully synthetic surgical mesh built on a dual-fiber design that resorbs gradually over roughly three years, giving tissue a long remodeling window before the scaffold disappears entirely, something biologic meshes and standard synthetics don't offer in combination.

How does TIGR Matrix compare to permanent surgical mesh for hernia repair?

Permanent mesh stays in the body indefinitely, which carries long-term risks like chronic pain, migration, and erosion in some patients. TIGR Matrix supports the tissue through the critical healing window, then resorbs, leaving native tissue to carry the load on its own.

What is the resorption timeline for TIGR Matrix?

One fiber resorbs faster to preserve early elasticity, the second holds strength longer. Full resorption completes over roughly three years.

Is TIGR Matrix appropriate for abdominal wall reconstruction?

Yes, it's one of the primary indications, particularly for patients where permanent mesh isn't the preferred long-term option due to age, wound class, or prior mesh complications.

What are the advantages of a resorbable mesh over a biologic mesh?

Biologic mesh resorbs faster with a less predictable strength curve, and it costs a lot more. TIGR Matrix gives a more predictable strength profile at a materially lower cost per case.

What sizes and configurations does TIGR Matrix come in?

A range of sheet sizes for different defect dimensions. Worth confirming current options against the IFU or with a Conduit rep since these do get updated.

Is there long-term clinical data on TIGR Matrix outcomes?

Yes, published outcomes extend several years post-implantation, tracking recurrence and mesh-related complications against both permanent synthetic and biologic alternatives.

What is the recommended handling and suturing technique for TIGR Matrix?

Handles similarly to standard synthetic mesh for suturing and fixation. Surgeons new to it should still check the IFU's orientation guidance, since the dual-fiber structure has a directional component that's easy to miss the first time.

How do I request a demo or sample of TIGR Matrix for my surgical team?

Through the request form on the product page or directly through your Conduit rep. In-services typically cover handling, sizing, and case selection.

Who is the manufacturer and distributor of TIGR Matrix, and how do I place an order?

Conduit is the authorized distributor for TIGR Matrix in the territories we serve. Orders should go through your Conduit account rep rather than the manufacturer directly.

Is TIGR Matrix indicated for contaminated or clean-contaminated surgical fields?

This genuinely depends on wound class and surgeon judgment, since stewardship committees ask this often and deserve a real answer rather than a blanket yes or no. Best to confirm against the current IFU or bring it to the clinical team directly.

Close-up of textured, white, non-woven fabric material with a pattern of small holes.

TIGR® MATRIX

TIGR® Matrix is the world’s first long-term, resorbable, 100% synthetic surgical mesh, designed to provide dynamic support for reconstructive surgery through a unique dual-stage degradation process that aligns with natural healing.

The mesh is crafted from high-quality synthetic multifilament fibers, a key factor in its effectiveness. These fibers include fast-resorbing strands that degrade within 4 months and slow-resorbing strands that maintain strength up to 36 months. This design enhances tissue integration, minimizes complications, and leaves behind strong, stable connective tissue, making TIGR® Matrix a versatile and dependable choice for surgeons seeking reliable, long-term outcomes in procedures like abdominal wall and hernia repair.

TIGR MATRIX IS CURRENTLY AVAILABLE IN 3 SIZES:

NSTM1520, 15 x 20 cm

NSTM1015, 10 x 15 cm

NSTM2030, 20 x 30 cm

Learn more

Your Questions, Answered

TIGR Matrix is a fully synthetic surgical mesh built on a dual-fiber design that resorbs gradually over roughly three years, giving tissue a long remodeling window before the scaffold disappears entirely, something biologic meshes and standard synthetics don't offer in combination.
Permanent mesh stays in the body indefinitely, which carries long-term risks like chronic pain, migration, and erosion in some patients. TIGR Matrix supports the tissue through the critical healing window, then resorbs, leaving native tissue to carry the load on its own.
One fiber resorbs faster to preserve early elasticity, the second holds strength longer. Full resorption completes over roughly three years.
Yes, it's one of the primary indications, particularly for patients where permanent mesh isn't the preferred long-term option due to age, wound class, or prior mesh complications.
Biologic mesh resorbs faster with a less predictable strength curve, and it costs a lot more. TIGR Matrix gives a more predictable strength profile at a materially lower cost per case.
A range of sheet sizes for different defect dimensions. Worth confirming current options against the IFU or with a Conduit rep since these do get updated.
Yes, published outcomes extend several years post-implantation, tracking recurrence and mesh-related complications against both permanent synthetic and biologic alternatives.
Handles similarly to standard synthetic mesh for suturing and fixation. Surgeons new to it should still check the IFU's orientation guidance, since the dual-fiber structure has a directional component that's easy to miss the first time.
Item Through the request form on the product page or directly through your Conduit rep. In-services typically cover handling, sizing, and case selection.
Conduit is the authorized distributor for TIGR Matrix in the territories we serve. Orders should go through your Conduit account rep rather than the manufacturer directly.
This genuinely depends on wound class and surgeon judgment, since stewardship committees ask this often and deserve a real answer rather than a blanket yes or no. Best to confirm against the current IFU or bring it to the clinical team directly.